HerbalHerbal

Rosabella Moringa: What the FDA Recall Says

A lot-specific Class I recall of Rosabella moringa capsules, from the FDA record. This is not a finding about every moringa product, and it is not a test Evident ran.

By Evident Editorial•11 min read

✓ Updated November 3, 2026

⚡

Quick Summary

Ambrosia Brands recalled certain lots of Rosabella moringa capsules on February 13, 2026, for possible Salmonella. FDA classed that recall Class I. The outbreak investigation later counted 10 illnesses. Check the lot code. Do not treat a terminated recall as a reason to ignore a bottle that is still in the house.

1OpenFDA record H-0546-2026: Class I, 1,224,208 units, 60-count bottles, status Terminated on August 13, 2026.

2FDA and CDC: 10 people infected in 8 states, 3 hospitalizations, no deaths. Strains were Salmonella Newport and Salmonella Kentucky.

3FDA could not determine the contamination source. It did say the affected powder came from a single supplier.

4The company’s February 13 notice counted 7 illnesses. The later CDC and FDA investigation count is 10. Both dates are on this page.

What was recalled

On February 13, 2026, Ambrosia Brands, LLC of New York recalled certain lots of Rosabella Moringa Capsules, 60-count bottles, because of possible Salmonella. The FDA company announcement says the product had been sold nationwide since February 2025 through tryrosabella.com and TikTok Shop, and that the firm was aware of possible unauthorized sales on eBay, Shein, and other sites. The firm said none of the impacted lots were sold by it on Amazon, and still told buyers to check lot numbers on any Rosabella moringa capsules bought there.

The openFDA enforcement record for H-0546-2026, which we read on November 3, 2026, lists the recalling firm as Ambrosia Brands LLC, classification Class I, product quantity 1,224,208 units, initiation date February 13, 2026, classification date March 9, 2026, and status Terminated with a termination date of August 13, 2026. The reason line is “Product may be contaminated with Salmonella.” The product description is Rosabella brand moringa dietary supplement capsules, 60 per bottle, UPC 8 60012 16172 0, with a suggested use of two veggie capsules once a day. That description is the recalled product in the FDA record. We did not open a live shop page on November 3, so this review does not describe a bottle the brand may be selling now.

FDA defines Class I as a situation in which there is a reasonable probability that use of, or exposure to, a violative product will cause serious adverse health consequences or death. “Terminated” means FDA determined that reasonable efforts to remove or correct the product were made. It does not mean a recalled bottle still in a cupboard is fine. The outbreak page says the product should no longer be for sale but has a long shelf life, and that people should check their homes.

What the outbreak investigation counted

The FDA outbreak page, updated through the close of the investigation, says CDC declared the outbreak over and FDA’s investigation is closed. It reports 10 people infected with the outbreak strains of Salmonella Newport and Salmonella Kentucky, from 8 states (Arizona, Florida, Iowa, Illinois, Indiana, Tennessee, Virginia, and Washington). Illness dates ran from September 26, 2025, to January 8, 2026. Of 8 people interviewed, 7 reported eating Rosabella-brand moringa powder capsules. There were 3 hospitalizations and no deaths.

FDA says those strains are resistant to all first-line and alternative antibiotics commonly recommended for the treatment of Salmonella infections. The page title calls the outbreak extensively drug-resistant. This page does not add a drug-by-drug list the agency’s public page does not print in the summary we read.

The Indiana Department of Health collected unopened product from a sick person’s home. That sample tested positive for Salmonella Newport, and whole-genome sequencing matched it to the outbreak strain. FDA says the positive product was included in the recall.

The company’s February 13 announcement said there had been 7 illnesses and 3 hospitalizations, and that FDA and CDC had reported the outbreak may be linked to the capsules. The later investigation total is 10 illnesses. Use the dated FDA and CDC pages for the final count, not the earlier company sentence.

FDA’s traceback line, in its words: it was not able to determine a source of contamination, and it did identify that the affected moringa powder came from a single supplier. All Rosabella-brand moringa products manufactured with powder from that supplier were recalled. FDA said screening of imported moringa was continuing as prevention. CDC’s outbreak page says this outbreak was not the agency’s other January 2026 Salmonella investigation of dietary supplements containing moringa leaf powder.

How to check a lot code

The FDA announcement says the lot code is printed on the bottom of the white plastic bottle, and that it is the middle seven digits of the code above the expiration date.
Affected codes start with SKU 1356 and end in -1 or -2 after the lot code. Expiration dates on the recalled lots run from 03/2027 to 11/2027.
CDC says the recall covers 52 lot codes. The full lot-and-expiration list is on the FDA announcement and in the openFDA code field. Match your bottle to that list rather than to a shortened copy.
If the lot matches, FDA says do not eat it. Throw it away, and clean surfaces the bottle touched. The company asked customers to dispose of listed lots and not to eat, sell, or serve them.
A lot that is not on the list is not cleared by this page. This recall does not test any other brand.

What this does not say about moringa

The recall is lot-specific and supplier-specific in the FDA write-up. It is not a survey of moringa powders in general, and Evident has no lab result of its own on any moringa product. Human-trial limits, pregnancy notes, and how to read a leaf-powder label are on moringa benefits. What to ask for on a certificate of analysis is on best moringa supplement.

We are not making a contamination claim about any brand that is not named in the FDA record above.

Sources

How we checked

On November 3, 2026 we read the FDA company announcement, the FDA outbreak page, the CDC outbreak page, and the openFDA record for H-0546-2026. Class, unit count, dates, illness totals, states, and the single-supplier sentence are from those pages.

The company’s February 13 illness count (7) and the later investigation count (10) are both printed, with their dates. We did not open a current Rosabella product page, so no current price or current label is included.

Evident did not test any moringa product. No affiliate link is used.

Common Questions

Frequently Asked Questions

Rosabella moringa capsules are a real product that Ambrosia Brands sold and then recalled in certain lots. The FDA record is about possible Salmonella in those lots. It is not a review of whether moringa leaf has a health effect. See the moringa benefits guide for the trials.

Yes. The openFDA record H-0546-2026 classifies it Class I, quantity 1,224,208 units, status Terminated as of August 13, 2026. Class I is FDA’s highest recall class. Terminated means the agency closed the removal effort. It does not clear a matching bottle that is still at home.

The FDA and CDC investigation reports 10 illnesses in 8 states, 3 hospitalizations, and no deaths. The company’s February 13, 2026 announcement had said 7 illnesses. Use the investigation total.

The recalled risk in the FDA notice is Salmonella infection, not a typical supplement side-effect list. The agency’s announcement describes fever, diarrhea, nausea, vomiting, and abdominal pain, and more severe illness in some people. That is the recall organism, not a measured effect of moringa leaf in a trial. For pregnancy and other cautions, see moringa side effects.

No. FDA said it could not find the contamination source and that the affected powder came from one supplier. Products made with that supplier’s powder were recalled. This page does not test or rank other brands.